Acting Director, Office of Biostatistics, Office of Translational Sciences, CDER, FDA
Dr. Chakravarty joined CDER in 1992. She served as an Adjunct Faculty in Depart. of Statistics, Foundation for Advanced Education in the Sciences, NIH. She is an internationally recognized thought leader in the area of safety evaluation, surrogate markers and biomarkers in drug development...
Read More →
Senior Research Advisor, Global Statistical Sciences, Eli Lilly and Company
Brenda Crowe is a Senior Research Advisor at Eli Lilly and Company (Lilly) where she leads a Safety Analytics team. She obtained a PhD in Statistics from the University of Toronto in 1997 and has 20 years of pharmaceutical industry experience.
BH
Associate Professor, Senior Biostatistician, Institute of Health Policy, Management and Evaluation (IHPME), Univ of Toronto
Dr. Hansen mentors PhD candidates in their clinical research which is reflected in a high productivity with over 230 publications. In collaboration with national and international scientists, she has coordinated several large impact studies on treatment for viral hepatitis and autoimmune...
Read More → MM
Mathematical Statistician, OB, OTS, CDER, FDA
Min Min received her PhD in Statistics from University of Maryland, College Park in December 2007. She joined the FDA in June 2008 and worked as a statistical reviewer with Pharmacology and Toxicology team for the six and half years. Currently, she is a stat reviewer for Division...
Read More → 
